3 studies found for:    17075123 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Tarceva Italian Lung Optimization tRial
Condition: Non Small Cell Lung Cancer (NSCLC)
Interventions: Drug: Erlotinib;   Drug: Docetaxel
2 Recruiting Gefitinib or Docetaxel as Second Line Therapy for Wild-type Epidermal Growth Factor Receptor (EGFR) NSCLC
Condition: Non-small Cell Lung Cancer
Interventions: Drug: Gefitinib;   Drug: Docetaxel
3 Recruiting Vinorelbine-ifosfamide Versus Gefitinib for EGFR Gene Mutation Negative Non-small Cell Lung Cancer Patients
Conditions: Non-small Cell Lung Cancer;   Effects of Chemotherapy
Interventions: Drug: Gefitinib group;   Drug: Vinorelbine, Ifosfamide, Mesna

Indicates status has not been verified in more than two years